Cargando…

Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study

PURPOSE: Treatment of spinal anesthesia-induced hypotension in patients with severe preeclampsia assumes special concern as hypotension may further reduce placental perfusion. Phenylephrine is still the first-line vasopressor for treating spinal anesthesia-induced hypotension. However, the optimal d...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jin-Ping, Pan, Zheng-Bin, Zhu, Miao, Zhu, Guo-Wei, Song, Da-Bing, Chen, Xin-Zhong, Qian, Xiao-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434829/
https://www.ncbi.nlm.nih.gov/pubmed/34522082
http://dx.doi.org/10.2147/DDDT.S323715
_version_ 1783751685955387392
author Liu, Jin-Ping
Pan, Zheng-Bin
Zhu, Miao
Zhu, Guo-Wei
Song, Da-Bing
Chen, Xin-Zhong
Qian, Xiao-Wei
author_facet Liu, Jin-Ping
Pan, Zheng-Bin
Zhu, Miao
Zhu, Guo-Wei
Song, Da-Bing
Chen, Xin-Zhong
Qian, Xiao-Wei
author_sort Liu, Jin-Ping
collection PubMed
description PURPOSE: Treatment of spinal anesthesia-induced hypotension in patients with severe preeclampsia assumes special concern as hypotension may further reduce placental perfusion. Phenylephrine is still the first-line vasopressor for treating spinal anesthesia-induced hypotension. However, the optimal dose of phenylephrine used as intravenous (IV) boluses in patients with severe preeclampsia has not been clearly determined. We aim to calculate the 90% effective dose (ED(90)) of phenylephrine as IV boluses for treating spinal anesthesia-induced hypotension in patients with severe preeclampsia undergoing cesarean delivery. PATIENTS AND METHODS: Forty patients with severe preeclampsia were enrolled in this prospective sequential allocation dose-finding trial. Using the biased coin up-and-down (BCUD) method, all patients in our study received an IV bolus phenylephrine of either 40, 50, 60, 70, or 80 µg when the mean arterial pressure (MAP) decreased to less than 80% of the baseline level and the ED(90) was determined. The primary outcome was the success of the assigned phenylephrine bolus to maintain the MAP at or above 80% of baseline value between the induction of spinal anesthesia and delivery of the fetus. Secondary outcomes included hypertension, nausea, vomiting, bradycardia, upper sensory level of anesthesia, umbilical blood gases, and Apgar score. Estimating of the ED(90) with 95% confidence interval (CI) was achieved by isotonic regression method. RESULTS: The ED(90) of phenylephrine was estimated as 62.00 µg (95% CI=50.00–67.40 µg) using the isotonic regression method. No patients enrolled in our study experienced bradycardia and those patients who developed hypertension were all observed at the dose level 70 µg. CONCLUSION: For clinical practice, we recommend that phenylephrine 60 µg may be both effective and safe for treatment of spinal anesthesia-induced hypotension in severe preeclampsia during cesarean delivery.
format Online
Article
Text
id pubmed-8434829
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84348292021-09-13 Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study Liu, Jin-Ping Pan, Zheng-Bin Zhu, Miao Zhu, Guo-Wei Song, Da-Bing Chen, Xin-Zhong Qian, Xiao-Wei Drug Des Devel Ther Original Research PURPOSE: Treatment of spinal anesthesia-induced hypotension in patients with severe preeclampsia assumes special concern as hypotension may further reduce placental perfusion. Phenylephrine is still the first-line vasopressor for treating spinal anesthesia-induced hypotension. However, the optimal dose of phenylephrine used as intravenous (IV) boluses in patients with severe preeclampsia has not been clearly determined. We aim to calculate the 90% effective dose (ED(90)) of phenylephrine as IV boluses for treating spinal anesthesia-induced hypotension in patients with severe preeclampsia undergoing cesarean delivery. PATIENTS AND METHODS: Forty patients with severe preeclampsia were enrolled in this prospective sequential allocation dose-finding trial. Using the biased coin up-and-down (BCUD) method, all patients in our study received an IV bolus phenylephrine of either 40, 50, 60, 70, or 80 µg when the mean arterial pressure (MAP) decreased to less than 80% of the baseline level and the ED(90) was determined. The primary outcome was the success of the assigned phenylephrine bolus to maintain the MAP at or above 80% of baseline value between the induction of spinal anesthesia and delivery of the fetus. Secondary outcomes included hypertension, nausea, vomiting, bradycardia, upper sensory level of anesthesia, umbilical blood gases, and Apgar score. Estimating of the ED(90) with 95% confidence interval (CI) was achieved by isotonic regression method. RESULTS: The ED(90) of phenylephrine was estimated as 62.00 µg (95% CI=50.00–67.40 µg) using the isotonic regression method. No patients enrolled in our study experienced bradycardia and those patients who developed hypertension were all observed at the dose level 70 µg. CONCLUSION: For clinical practice, we recommend that phenylephrine 60 µg may be both effective and safe for treatment of spinal anesthesia-induced hypotension in severe preeclampsia during cesarean delivery. Dove 2021-09-07 /pmc/articles/PMC8434829/ /pubmed/34522082 http://dx.doi.org/10.2147/DDDT.S323715 Text en © 2021 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Jin-Ping
Pan, Zheng-Bin
Zhu, Miao
Zhu, Guo-Wei
Song, Da-Bing
Chen, Xin-Zhong
Qian, Xiao-Wei
Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study
title Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study
title_full Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study
title_fullStr Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study
title_full_unstemmed Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study
title_short Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study
title_sort determination of the 90% effective dose of phenylephrine boluses to treat spinal anesthesia-induced hypotension in patients with severe preeclampsia during cesarean delivery: a pilot study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434829/
https://www.ncbi.nlm.nih.gov/pubmed/34522082
http://dx.doi.org/10.2147/DDDT.S323715
work_keys_str_mv AT liujinping determinationofthe90effectivedoseofphenylephrinebolusestotreatspinalanesthesiainducedhypotensioninpatientswithseverepreeclampsiaduringcesareandeliveryapilotstudy
AT panzhengbin determinationofthe90effectivedoseofphenylephrinebolusestotreatspinalanesthesiainducedhypotensioninpatientswithseverepreeclampsiaduringcesareandeliveryapilotstudy
AT zhumiao determinationofthe90effectivedoseofphenylephrinebolusestotreatspinalanesthesiainducedhypotensioninpatientswithseverepreeclampsiaduringcesareandeliveryapilotstudy
AT zhuguowei determinationofthe90effectivedoseofphenylephrinebolusestotreatspinalanesthesiainducedhypotensioninpatientswithseverepreeclampsiaduringcesareandeliveryapilotstudy
AT songdabing determinationofthe90effectivedoseofphenylephrinebolusestotreatspinalanesthesiainducedhypotensioninpatientswithseverepreeclampsiaduringcesareandeliveryapilotstudy
AT chenxinzhong determinationofthe90effectivedoseofphenylephrinebolusestotreatspinalanesthesiainducedhypotensioninpatientswithseverepreeclampsiaduringcesareandeliveryapilotstudy
AT qianxiaowei determinationofthe90effectivedoseofphenylephrinebolusestotreatspinalanesthesiainducedhypotensioninpatientswithseverepreeclampsiaduringcesareandeliveryapilotstudy